Join
Live feed
·
INSIDERFilingvia Quantisnow
Rigel Pharmaceuticals Inc. logo

EVP & Chief Financial Officer Schorno Dean L was granted 19,717 shares, increasing direct ownership by 48% to 61,005 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
RIGL· Rigel Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RIGL (Rigel Pharmaceuticals Inc.) and more on Quantisnow.